Vonderheide, Robert H.
University of Pennsylvania,
United States
2025 Rank: 3345
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 81 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 3345 | 3467 |
| Total Cites | 3908 | 4054 |
| H-index | 29 | 31 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 124 | 125 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 266 | 270 |
| Number of Single+First+Last Authored Papers | 115 | 115 |
| Total Cites to Single+First+Last Authored Papers | 1045 | 1089 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3061 | 3130 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.30 |
| Self-Citation Percentage |
3.60%
|
|
Vonderheide, Robert H.
Penn Medicine,
United States
2024 Rank: 2576
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 68 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2576 | 3056 |
| Total Cites | 3810 | 3926 |
| H-index | 29 | 29 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 9 | 9 |
| Total Cites to Single Authored Papers | 141 | 143 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 276 | 279 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 1073 | 1101 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3009 | 3063 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.28 |
| Self-Citation Percentage |
2.95%
|
|
Vonderheide, Robert H.
Penn Medicine,
United States
2023 Rank: 2556
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 76 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2556 | 3047 |
| Total Cites | 3923 | 4031 |
| H-index | 29 | 29 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 129 | 129 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 312 | 314 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 1151 | 1167 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3116 | 3184 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
2.68%
|
|
Vonderheide, Robert H.
Penn Medicine,
United States
2022 Rank: 1844
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 57 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 1844 | 1869 |
| Total Cites | 3873 | 4093 |
| H-index | 29 | 30 |
| Hm-index | 11 | 11 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 157 | 166 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 375 | 390 |
| Number of Single+First+Last Authored Papers | 109 | 109 |
| Total Cites to Single+First+Last Authored Papers | 1277 | 1349 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2914 | 3004 |
| Ratio of Total Citations to Distinct Citing Papers | 1.33 | 1.36 |
| Self-Citation Percentage |
5.38%
|
|
Vonderheide, Robert H.
Penn Medicine,
United States
2021 Rank: 2419
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 61 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 2419 | 2396 |
| Total Cites | 5151 | 5508 |
| H-index | 34 | 34 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 201 | 218 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 522 | 552 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 1657 | 1799 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3904 | 4035 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.37 |
| Self-Citation Percentage |
6.48%
|
|
Vonderheide, Robert H.
University of Pennsylvania Perelman School of Medicine,
United States
2020 Rank: 4690
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 114 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 4690 | 4816 |
| Total Cites | 3078 | 3314 |
| H-index | 25 | 26 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 99 | 102 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 322 | 335 |
| Number of Single+First+Last Authored Papers | 97 | 97 |
| Total Cites to Single+First+Last Authored Papers | 997 | 1076 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2397 | 2500 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.33 |
| Self-Citation Percentage |
7.12%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.